Inserm le magazine : La leucémie lymphoblastique aiguë de type B (LAL-B) est un cancer du sang associé à un mauvais pronostic, qui…
L’INSERM, l’Université de Rennes 1 et le CNRS organisent la venue de Thomas d’Ansembourg pour une conférence de sensibilisation à la…
From September 6, 2022 to August 8, 2023 At the City of Science and Industry In September 2022, at the…
EExtract from the web documentary "Cancer Research: Everything is Accelerating" co-produced by the National Cancer Institute, the…
Extract from the web documentary "Cancer Research: Everything is Accelerating" co-produced by the National Cancer Institute, the…
With Karin Tarte, Director of Inserm Unit 917, Anne Vincent-Salomon, Pathologist at Inserm Unit 830, Fabrice André, Director of Inserm Unit…
What is immunotherapy? Where does this approach come from? Why is this therapy said to be “revolutionary” and bring a drastic change in the…
CANCERS Du 6 septembre 2022 au 8 août 2023 À la Cité des sciences et de l’industrie « Médecins, chercheurs,…